This week the Alliance for Aging Research and the U.S. Administration on Aging (AoA) released a new white paper titled Translating Innovation to Impact: Evidence-based interventions to support people with Alzheimer's disease and their caregivers at home and in their communities. The white paper was written by Katie Maslow, MSW, Scholar-in-Residence at the Institute of Medicine, but the findings in the paper are the result of a review of the state of the art of non-pharmacological treatments and care practices that began with a public-private meeting on June 28, 2012.
Heterogeneity or Just Plain ol’ Differences?
The Alliance for Aging Research was pleased to be a co-sponsor of the National Pharmaceutical Council’s Myth of the Average Patient Conference in Washington, D.C. I had the opportunity to attend the event and share my thoughts on why the topic of heterogeneity among patients is important to consider when conducting comparative effectiveness research.
REPORT: The Medicare Advantage Experience
Full report can be found here:The_Medicare_Advantage_Experience (PDF Format)
